A Randomized Crossover Oral Bioavailability Study Comparing the Pharmacokinetics and Pharmacodynamics of Picoplatin Administered Orally With Picoplatin Administered Intravenously in Subjects With Advanced Non-Hematological Malignancies.
Phase of Trial: Phase I
Latest Information Update: 25 Aug 2009
At a glance
- Drugs Picoplatin; Picoplatin
- Indications Cancer; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 25 Aug 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 21 Apr 2009 Final results have been reported at the 100th Annual Meeting of the American Association for Cancer Research (AACR-2009)
- 18 Nov 2008 Final top-line results reported in a Poniard media release. Endpoints achieved.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History